BISOPROLOL/HYDROCHLOROTHIAZIDE ARROW LAB 2.5 mg/6.25 mg, film-coated tablet CIP 3400930200919
Active ingredients: Bisoprolol monofumarate, HYDROCHLOROTHIAZIDE
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tabletCIP 3400930200919orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BISOPROLOL/HYDROCHLOROTHIAZIDE ARROW LAB 2,5 mg/6,25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 30
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Apr 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68579276CIP73020091CIP133400930200919Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCHLOROTHIAZIDEcomprimé | 6,25 mg · un comprimé | SA |
| FUMARATE DE BISOPROLOLcomprimé | 2,50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.